Table 4.
Patient Characteristics of Subset Tested for Immune Parameters
| Patients With Immune Tests (n = 53) |
Patients Not Immune Tested (n = 68) |
All Patients (N = 121) |
||||
|---|---|---|---|---|---|---|
| Characteristic | No. | % | No. | % | No. | % |
| Sex | ||||||
| Male | 31 | 41 | 72 | |||
| Female | 22 | 27 | 49 | |||
| Age, years | ||||||
| Median | 50 | 50 | 50 | |||
| Range | 21-69 | 20-76 | 20-76 | |||
| ECOG PS | ||||||
| 0 | 43 | 56 | 99 | |||
| 1 | 10 | 12 | 22 | |||
| Trial | ||||||
| Trial 1 | 21 | 39 | 21 | 31 | 42 | |
| Trial 2 | 13 | 25 | 27 | 40 | 40 | 33 |
| Trial 3 | 19 | 36 | 20 | 29 | 39 | 32 |
| AJCC staging | ||||||
| M1a | 4 | 8 | 9 | 13 | 13 | 11 |
| M1b | 15 | 28 | 12 | 18 | 27 | 22 |
| M1c | 34 | 64 | 47 | 69 | 81 | 67 |
| Prior therapy | ||||||
| Interferon alfa | 21 | 40 | 21 | 31 | 42 | 34 |
| Chemotherapy | 5 | 9 | 10 | 15 | 15 | 13 |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; PS, performance status; AJCC, American Joint Committee on Cancer.